Topic:

Infectious Diseases

Latest Headlines

Latest Headlines

FDA animal study: Whooping cough vaccine fails to stop the disease's spread

For most of the second half of the 20th century, whooping cough was a disease of the past, one of many previously common infections practically eliminated by vaccines. Since the 1980s the bacteria has fought back though, and now FDA researchers have a theory why--vaccines might not be stopping transmission.

The argument for vaccinating: 100M cases of disease prevented in U.S.

For many people, vaccines trail only clean water on the list of interventions that have had the biggest effect on infectious diseases. Yet with many others fiercely opposed to vaccines, data is needed to support the argument. This week the data arrived, and it makes a strong case for the importance of vaccines.

Value of Pentagon-backed vaccine plant questioned

While few question the necessity of the Defense Department's investments in protecting military personnel from biological threats, the scale and type of projects is a source of considerable controversy, as shown by the Pentagon's latest push into vaccine manufacturing.

WHO updates malaria roadmap with 2030 vaccine goals

When the World Health Organization released its first malaria vaccine technology roadmap in 2006, it put the development of a partly effective vaccine by 2015 at the top of its list of priorities. With GlaxoSmithKline nearing that goal, WHO has revised its plan with new targets for 2030.

CDC to import unapproved Novartis vaccine to stem Princeton meningitis outbreak

As a meningitis outbreak has slowly spread across Princeton University over the past 8 months, the case for vaccinating students has grown stronger. The only hitch is that the vaccine, Novartis' Bexsero, has yet to win approval in the U.S. Now, though, health authorities are willing to work around this obstacle.

Novavax presents positive Phase I data for H7N9 vaccine

The reemergence of H7N9 in China during the past month has reinforced the need for a vaccine. Candidates from Chinese and Taiwanese manufacturers have grabbed the headlines recently, but now a U.S. player, Novavax, has joined the race with positive Phase I data.

Polio outbreak sparks fears refugees will carry virus to Europe

When the number of Syrians fleeing their war-torn state to live in neighboring countries topped two million, the United Nations refugee head called the situation a "humanitarian calamity." Now it is getting worse, with the potential for the refugees to carry polio across the Middle East and Europe causing alarm.

Agenus, Sanofi-NIH collaboration race to develop genital herpes vaccine

Agenus and a Sanofi-NIH collaboration both gave updates on their genital herpes vaccine candidates this week. The Agenus vaccine, HerpV, is leading the race, having met its primary endpoint in a Phase II trial of 80 subjects, 70 of whom received the treatment.

WHO massively scales up Middle East polio immunization plan

The polio outbreak in Syria has the World Health Organization worried. Just weeks after outlining a two-month, 10-million dose vaccination campaign, the United Nations' public health arm has escalated its plans. The new goal is to vaccinate 50 million kids across the Middle East over the next 8 months.

Takeda, Boehringer invest to move CMV vaccine into clinic

Having ticked candidates to protect against respiratory syncytial virus, dengue and norovirus off its list of areas of interest as part of its plans to establish a global vaccine business, Takeda has invested in another stated target: cytomegalovirus.